5-azacitidine prolongs overall survival in patients with myelodysplastic syndrome - systematic review and meta-analysis (Reply to Kumar et al. and to Herbst et al.)

被引：2
作者：
Gurion, Ronit
Vidal, Liat
Gafter-Gvili, Anat
Belnik, Yulia
Yeshurun, Moshe
Raanani, Pia
Shpilberg, Ofer
机构：
[1] Belinson Hosp, Rabin Med Ctr, Inst Hematol, Davidoff Canc Ctr, Tel Aviv, Israel
[2] Sackler Sch Med, Tel Aviv, Israel
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷 / 02期
关键词：
AZACITIDINE; DECITABINE;
D O I：
10.3324/haematol.2009.020420
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：343 / 344
页数：2
相关论文
共 7 条
[1]   Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study [J].
Fenaux, Pierre ;
Mufti, Ghulam J. ;
Hellstrom-Lindberg, Eva ;
Santini, Valeria ;
Finelli, Carlo ;
Giagounidis, Aristoteles ;
Schoch, Robert ;
Gattermann, Norbert ;
Sanz, Guillermo ;
List, Alan ;
Gore, Steven D. ;
Seymour, John F. ;
Bennett, John M. ;
Byrd, John ;
Backstrom, Jay ;
Zimmerman, Linda ;
McKenzie, David ;
Beach, C. L. ;
Silverman, Lewis R. .
LANCET ONCOLOGY, 2009, 10 (03) :223-232
[2]   5-azacitidine prolongs overall survival in patients with myelodysplastic syndrome - a systematic review and meta-analysis [J].
Gurion, Ronit ;
Vidal, Liat ;
Gafter-Gvili, Anat ;
BeInik, Yulia ;
Yeshurun, Moshe ;
Raanani, Pia ;
Shpilberg, Ofer .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02) :303-310
[3]   Meta-analysis on hypomethylating agents in myelodysplastic syndromes [J].
Herbst, Christine ;
Baner, Kathrin ;
Kreuzer, Karl-Anton .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02) :342-343
[4]   Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study [J].
Kantarjian, H ;
Issa, JPJ ;
Rosenfeld, CS ;
Bennett, JM ;
Albitar, M ;
DiPersio, J ;
Klimek, V ;
Slack, J ;
de Castro, C ;
Ravandi, F ;
Helmer, R ;
Shen, LL ;
Nimer, SD ;
Leavitt, R ;
Raza, A ;
Saba, H .
CANCER, 2006, 106 (08) :1794-1803
[5]   Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis [J].
Kumar, Ambuj ;
List, Alan F. ;
Hozo, Iztok ;
Komrokji, Rami ;
Djulbegovic, Benjamin .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02) :340-342
[6]   Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B [J].
Silverman, LR ;
Demakos, EP ;
Peterson, BL ;
Kornblith, AB ;
Holland, JC ;
Odchimar-Reissig, R ;
Stone, RM ;
Nelson, D ;
Powell, BL ;
DeCastro, CM ;
Ellerton, J ;
Larson, RA ;
Schiffer, CA ;
Holland, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2429-2440
[7]  
Wijermans P, 2008, BLOOD, V112, P241
1